Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLD
Authors:
- William A. MurphyWMWilliam A. Murphy
- Anna Mae DiehlADAnna Mae Diehl
- Matthew Shane LoopMLMatthew Shane Loop
- Dong FuDFDong Fu
- Cynthia D. GuyCGCynthia D. Guy
- Manal F. AbdelmalekManal F. Abdelmalek
- Georgia Sofia KarachaliouGKGeorgia Sofia Karachaliou
- Noora SjöstedtNSNoora Sjöstedt
- Sibylle NeuhoffSNSibylle Neuhoff
- Paavo HonkakoskiPHPaavo Honkakoski
- Kim L. R. BrouwerKBKim L. R. Brouwer
Open Access
- 14 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (3)
Abstract
Background: NAFLD is highly prevalent with limited treatment options. Bile acids (BAs) increase in the systemic circulation and liver during NAFLD progression. Changes in plasma membrane localization and zonal distribution of BA transporters can influence transport function and BA homeostasis. However, a thorough characterization of how NAFLD influences these factors is currently lacking. This study aimed to evaluate the impact of NAFLD and the accompanying histologic features on the functional capacity of key hepatocyte BA transporters across zonal regions in human liver biopsies. Methods: A novel machine learning image classification approach was used to quantify relative zonal abundance and plasma membrane localization of BA transporters (bile salt export pump [BSEP], sodium-taurocholate cotransporting polypeptide, organic anion transporting polypeptide [OATP] 1B1 and OATP1B3) in non-diseased (n = 10), NAFL (n = 9), and NASH (n = 11) liver biopsies. Based on these data, membrane-localized zonal abundance (MZA) measures were developed to estimate transporter functional capacity. Results: NAFLD diagnosis and histologic scoring were associated with changes in transporter membrane localization and zonation. Increased periportal BSEPMZA (mean proportional difference compared to non-diseased liver of 0.090) and decreased pericentral BSEPMZA (−0.065) were observed with NASH and also in biopsies with higher histologic scores. Compared to Non-diseased Liver, periportal OATP1B3MZA was increased in NAFL (0.041) and NASH (0.047). Grade 2 steatosis (mean proportional difference of 0.043 when compared to grade 0) and grade 1 lobular inflammation (0.043) were associated with increased periportal OATP1B3MZA. Conclusions: These findings provide novel mechanistic insight into specific transporter alterations that impact BA homeostasis in NAFLD. Changes in BSEPMZA likely contribute to altered BA disposition and pericentral microcholestasis previously reported in some patients with NAFLD. BSEPMZA assessment could inform future development and optimization of NASH-related pharmacotherapies.Keywords
This publication has 48 references indexed in Scilit:
- Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver DiseaseDrug Metabolism and Disposition, 2011
- Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liverJournal of Hepatology, 2011
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary AtresiaPediatric Research, 2008
- Bile acid levels are increased in the liver of patients with steatohepatitisEuropean Journal of Gastroenterology & Hepatology, 2008
- Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and PharmacogeneticsGastroenterology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosisJournal of Hepatology, 2003
- Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivativeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1980